Effect of interleukin 1b inhibition with canakinumab on inflammation and viral persistence in people with human immunodeficiency virus

Back

ESC Professional Premium Access

Effect of interleukin 1b inhibition with canakinumab on inflammation and viral persistence in people with human immunodeficiency virus

Session: HIV and cardiovascular disease (1)

Topic: HIV and Cardiovascular Disease

Speaker: Assistant Professor M. Durstenfeld (San Francisco, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Assistant Professor Matthew Durstenfeld

University of California at San Francisco, San Francisco (United States of America)

0 follower

8 more presentations in this session

Large-scale proteomic profiling reveals characteristic HIV-specific druggable protein signatures associated with incident heart failure

Speaker: Doctor S. Shakil (Los Angeles, US)

Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis.

Speaker: Professor N. Vuilleumier (Geneva, CH)

Influence of disturbed blood flow on endothelial function in people living with HIV

Speaker: Doctor A. Preveden (Sremska Kamenica, RS)

Impaired retinal micro-vascular function in patients with a systemic sclerosis

Speaker: Ms N. Laptseva (Zurich, CH)

Reduction of aortic stiffness in newly diagnosed persons with HIV-infection: modifiable vascular dysfunction after antiretroviral therapy?

Speaker: Doctor P. Robbertse (Cape Town, ZA)

Access the full session

HIV and cardiovascular disease (1)

Speakers: Assistant Professor M. Durstenfeld, Doctor S. Shakil, Professor N. Vuilleumier, Doctor A. Preveden, Ms N. Laptseva...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources